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Abstract
We investigated the association between serum valproic acid (VPA) levels and clinical
conditions  in  patients  after  acute  intoxication  with  this  drug.  We  performed  a
retrospective study of cases of VPA intoxications hospitalized in Toxicology Unit in
Cracow in 2 years of observation. The study included 26 patients (age: 35.69 ± 12.93
years). In all patients, the VPA plasma level was higher than the therapeutic range,
mean ± SD: 275.32 ± 135.97 μg/ml. About half of poisoned patients described in this
report were treated with VPA prior to the poisoning. We noted four cases of mixed
VPA intoxications with ethanol. Acute pulmonary failure was observed in two persons.
The mean hospital stay for all patients was 4.69 days. This analysis demonstrates that
increased serum VPA levels, in acute intoxication with this drug, were associated with
the severity of poisoning — in PSS (P = 0.019) and in Matthews coma scale (P = 0.022),
diastolic pressure (P = 0.022) and length of stay in hospital (P = 0.001). No correlation
was detected between the serum VPA concentration and the heart rate and systolic
blood pressure. In persons treated with VPA earlier, the course of poisoning was less
severe, although these results were not statistically significant.
Keywords: valproic acid, acute intoxication, clinical manifestations, drug serum level,
toxicity
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1. Introduction
Valproic acid (VPA) (and its derivatives) is a commonly used conventional antiepileptic drugs
(AED) for pharmacotherapy in epileptic patients. VPA was introduced in 1978 as AED [1].
Valproic acid is  characterized by multidirectional  action that  involves increased gamma-
aminobutyric acid (GABA)-ergic transmission, reduced release and/or effects of excitatory
amino acids, blockage of voltage gated sodium channels and modulation of dopaminergic and
serotonergic transmission [2]. This drug is effective in patients with all types of seizures, and
especially in those with idiopathic generalized epilepsy [3, 4]. It is also prescribed to treat
bipolar and schizoaffective disorders, social phobias and neuropathic pain, as well as for
prophylaxis and treatment of migraine headache [5–9]. Valproic acid is a fatty acid which is
about 90% bound to plasma proteins and the main metabolic transformations of valproic acid
take place in liver, including that of the cytochrome P-450. Valproic acid follows a non-linear
pharmacokinetic profile in terms of protein-binding saturation [10]. Acute VPA intoxication
also occurs as a consequence of suicidal or accidental overdose. VPA intoxication incidence is
increasing [11–14], probably because of its use in psychiatric disorders. It usually results in
mild and self-limited central nervous system depression. However, serious toxicity and even
deaths have been reported [15, 16]. The therapeutic serum concentrations for VPA are 50–100
μg/ml [17, 18]. Monitoring VPA serum levels helps to evaluate therapeutic response, compli-
ance and possible toxicity.
2. Aim
The aim of study was to evaluate plasma concentrations of VPA and the clinical symptoms of
acute intoxication.
3. Materials and methods
We performed a retrospective study of all cases of VPA intoxications (n = 31) hospitalized in
Toxicology Unit in Cracow in 2 years of observation. A total of 26 patients who fulfilled in-
clusion and exclusion criteria were included in this study. The inclusion criteria were pa-
tients should be at least 18 years of age and documented serum VPA concentration should
be ≥100 μg/ml. Patients taking VPA with other drugs which have an effect on VPA pharma-
cokinetic (i.e. carbamazepine, benzodiazepine, barbiturate) and patients with abnormal re-
nal or liver function tests were excluded. From the medical records, relevant demographic
data were taken, i.e. age and gender. The clinical spectrum consisted of consciousness dis-
turbances, breath, heart rate, blood pressure, serum level of VPA, severity of poisoning,
length of stay in hospital and treatment effect (survival/death). The project was reviewed
and approved by the Ethics Committee, Medical University of Warsaw (no. AKBE/32/13).
The level of consciousness was graded on a scale of 0–IV according to Matthew and Lawson
coma scale. Matthew-Lawson coma scale of determining severity of coma: grade 0—fully
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conscious, alert; grade I—drowsy but responds to verbal command; grade II—unconscious
patient but responds to minimal painful stimuli, reflexes intact; grade III—unconscious patient
but responds to maximal painful stimuli, absence of superficial reflexes and sluggish deep
reflexes; grade IV—unconscious patient with no response to painful stimuli, loss of all reflexes
including corneal, laryngeal, pharyngeal. Grades III and IV are considered as severe grades of
poisoning [19].
Severity of intoxication was classified according to Poisoning Severity Score (PSS). The PSS is
a classification scheme for cases of poisoning in adults and children. The PSS grades severity
as (0) none—no symptoms or signs related to poisoning, (1) minor—mild, transient and
spontaneously resolving symptoms, (2) moderate—pronounced or prolonged symptoms, (3)
severe—severe or life-threatening symptoms, and (4) fatal poisoning—death [20].
3.1. Statistical analysis
The data were collected in a Microsoft Excel database. Data are presented as mean and standard
deviations. Statistical analysis of all data was performed by Statistica version 12 using the
Pearson’s r, Spearman’s rho, Mann-Whitney U test. Differences were considered statistically
significant at P < 0.05.
4. Results
We studied episodes of hospitalization for VPA intoxication in 26 patients, of whom 9 were
men (34.61%). The mean age was 35.69 ± 12.93 years (range: 18–73 years) (Table 1).
Characteristics N (%)
Gender
 Female 17 (65.39%)
 Male 9 (34.61%)
 Total 26 (100%)
Age, years
Range: 18–73
Mean ± SD: 35.69 ± 12.93
Table 1. Demographics characteristics of study population.
Half of the poisoned patients (50%) described in this report were treated with valproic acid
due to epilepsy or psychotic disorders prior to the poisoning. These patients had a less severe
clinical course of poison, although these results were not statistically significant (P = 0.09).
The following intensity of quantitative consciousness disturbances according to Matthew’s
scale was observed: grade 0—26.92%, I—26.92%, II—30.77%, and III—15.39%.
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Parameters
Systolic blood pressure (SBP), mmHg
 Range 100–160
 Mean ± SD 127.15 ± 16.55
Diastolic blood pressure (DBP), mmHg
 Range 50–100
 Mean ± SD 79.23 ± 12.25
Heart rate (HR), beats/min
 Range 58–122
 Mean ± SD 88.46 ± 17.58
Breath
 Competence of a respiration 24 (92.31%)
 Intubation 2 (7.69%)
Matthew coma scale (MCS)
 Grade 0 7 (26.92%)
 Grade 1 7 (26.92%)
 Grade 2 8 (30.77%)
 Grade 3 4 (15.39%)
 Grade 4 0 (0%)
Poisoning severity score (PSS)
 Minor 14 (53.85%)
 Moderate 7 (26.92%)
 Severe 5 (19.23%)
Ethanol, ‰
 Range 0–2.92
 Mean ± SD 0.305 ± 0.77
 Yes 4 (15.38%)
 No 22 (84.62%)
Co-morbidity
 Depression 7 (26.92%)
 Alcohol dependence syndrome 4 (15.38%)
 Personality disorder 5 (19.23%)
 Somatic disease 3 (11.54%)
 Bipolar disorder 2 (7.69%)
 Schizophrenia 4 (15.38%)
 Other mental disorder 5 (19.23%)
 Epilepsy 9 (34.62%)
Length of stay in hospital, days
 Range 2–13
 Mean ± SD 4.69 ± 2.57
Treatment effect
 Discharged from hospital in good condition 17 (65.39%)
 Discharged from hospital on a voluntary distractions 7 (26.92%)
 Referral to mental hospital/ward 2 (7.69%)
Toxic valproic acid level, μg/ml
 Range 110–660
 Mean ± SD 275.32 ± 135.97
Table 2. Clinical parameters distribution in examined population.
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The serum VPA concentration showed moderate positive correlations with Matthew’s scale
(Spearman’s rho = 0.45, P = 0.022).
The minimal and maximal values of blood pressure were: 100–160 and 50–100 mmHg,
respectively, for systolic and diastolic blood pressure; heart rate: 58–122 beats/min; breathing
rate in non-intubated patients: 13–20 breaths/min.
Correlational analysis (Pearson’s r) revealed a moderate negative correlation between the VPA
concentration and diastolic blood pressure (r = −0.45, P = 0.022). This negative correlation means
that when the VPA level is higher, the diastolic blood pressure is lower.
In the study population, no statistical correlation was found between the serum VPA concen-
tration and the heart rate (r = −0.01, P = 0.944), and systolic blood pressure (r = −0.09, P = 0.655).
Severity of intoxication was classified according to poisoning severity score (PSS). The PSS was
minor in 14 patients, moderate in 7 patients and severe in 5 patients.
A positive relationship between the decrease in number of PSS and the increasing VPA serum
level was demonstrated (Spearman’s rho = 0.46, P = 0.019).
A significant proportion of patients had comorbid mental health disorders (e.g. depression,
personality disorders, schizophrenia, and bipolar disorder).
Only two patients were inefficient to breathe and they required intubation. No patients had
arrhythmias and seizures.
Alcohol was co-ingested by four patients. The mean ethanol concentration was 0.305‰.
The mean length of hospital stay was 4.69 days. We observed strong correlation between the
serum level of VPA and the number of days of stay in hospital (r = 0.96; P = 0.001).
Seventeen of these 26 patients were discharged to home in good condition and two to a
psychiatric ward. There were no reported mortalities among the cases of VPA intoxications.
The mean of serum level of valproic acid was 275.32 ± 135.97 μg/ml.
The characteristics of clinical parameters are shown in Table 2.
5. Discussion
Despite the fact that valproic acid is an old generation antiepileptic drug, in the literature, there
is little information about the case series of VPA overdose. However, there is a description of
case reports of VPA intoxication [21–24].
In our study, a positive relationship between the decrease in number of PSS and the increasing
VPA serum level was demonstrated (Spearman’s rho = 0.46, P = 0.019). It has been observed that
the higher the concentration of VPA, the more severe the poisoning. In the literature, a serum
level of >450 μg/ml was more likely to be associated with a moderate or major adverse
outcome (P < 0.005) [11].
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Symptoms of VPA intoxication are diverse. The most common manifestation of overdose is
central nervous system (CNS) depression [25, 26]. Other studies show that some patients have
mild to moderate lethargy [13, 27]. It was noted that patients who ingest more than 200
mg/kg VPA and/or have plasma concentrations greater than 180 μg/ml usually develop severe
CNS depression [28]. Taking VPA at higher doses (>400 mg/kg) is associated with serious
consequences such as coma, cerebral oedema [29], metabolic acidosis, hyperammonemia,
thrombocytopenia and leukopenia, and circulatory collapse [11, 30, 31]. The study by Spiller
et al. [11] show that the concentration of VPA > 850 μg/ml was more likely to be associated
with coma ( P < 0.005). In a large multicentre review of 134 patients (80 with VPA levels in the
toxic range), 71% of patients presented with lethargy, and 15% were in coma [8]. In our study,
15.39% of patients were in stage III coma (Matthew’s scale). This study shows that the serum
VPA concentration showed moderate positive correlations with Matthew’s coma scale
(Spearman’s rho = 0.45, P = 0.022). This means that the higher the VPA concentration, the higher
its score on Matthew’s coma scale.
Other possible adverse effects of valproic acid on the nervous system include agitation,
hallucinations, tremors, myoclonus and seizures [28].
In addition to generally known symptoms, valproic acid intoxication may also be associated
with hypotension [32]. In this study, correlational analysis (Pearson’s r) revealed a moderate
negative correlation between VPA concentration and diastolic blood pressure (r = −0.45, P =
0.022). This negative correlation means that when the VPA level is higher, the diastolic blood
pressure is lower.
Other clinical findings include respiratory depression and acute respiratory distress syn-
drome [33, 34]. In the study by Tank et al. [35], all patients with serum levels higher than 850
μg/ml were comatose, and 63% of these patients needed intubation.
In our study, out of 26 patients, only two experienced respiratory depression and required
intubations. The first patient was a 49-year-old man, reportedly poisoned intentionally,
admitted to Toxicology Department. His valproate sodium serum concentration was 224.8
μg/ml. The serum level of other drugs and ethanol were all negative. He had a history of
psychiatric illness, including personality disorder and alcohol dependence syndrome. His vital
signs were as follows: pulse rate 115 beats/min, blood pressure 155/100 mmHg, temperature
36.6°C and respiratory insufficiency. On the day of admission, the patient was unconscious, in
the third stage coma by Matthew’s scale, with features of overt respiratory failure. The patient
was immediately intubated and connected to a respirator. After the first day the patient was
extubated, had efficient breathing, but with persistent disturbances of consciousness, period-
ically extremely agitated and psychotic. Gradually, the patient's condition experienced an
improvement. From the fifth day there was a logical, calm. When the serum levels returned to
normal, the patient made a complete recovery. On the seventh day of treatment, after psychi-
atric review, the patient was discharged home in good condition. The second patient was a 24-
year-old woman admitted to the Toxicology Department after attempting suicide by ingesting
tablets of valproic acid. Her valproate sodium serum concentration was high and peaked at
315 μg/ml. The serum level of other drugs and ethanol were all negative. She had a history of
psychiatric illness, including paranoid schizophrenia. The patient was confused, hallucinated
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and developed deep coma. In addition, the physical examination revealed tachycardia 120
beats/min and normal blood pressure (110/70 mmHg). Her core body temperature was 36.8°C.
In the early hours of observation, there were repeated spasms and respiratory insufficiency—
the patient was intubated and connected to a respirator. Gradually, the patient's condition
improved, and after 4 days of mechanical ventilation, the patient was extubated. In the fourth
day the patient was in contact and began to walk in the fifth. Because of the high risk of
recurrence of attempted suicide, the patient was urgently addressed without consent to the
psychiatric ward for further treatment. At the time of discharge, the patient did not require
hospitalization for toxicological reasons.
Haematological disturbances are rare, but there are potentially serious complication of chronic
valproate therapy and overdose [11, 13]. Spiller et al. [11] demonstrated that thrombocyto-
paenia (<150 tys/μl), occurred with valproate concentrations >450 μg/ml, but did not correlate
it with dose ingested, whereas fatal leukopenia (WBC < 1200 tys/μl) was observed in patients
with VPA concentrations >1200 μg/ml. Hypernatremia (Na+ > 145 mmol/l) and hypocalcaemia
were observed in patients with peak VPA concentrations >450 μg/ml [13].
In our study, there were no reported haematological disturbances among the cases of VPA
intoxications.
In our study, mean length of hospital stay for all patients was 4.69 days; in the study by Spiller
et al. [11], it was 42 ± 33.1 hours. In this study, statistical analysis found the relationship between
the serum concentration of VPA and the duration of stay in hospital (P = 0.001) and that the
higher the drug concentration, the longer the length of stay in hospital for the patients.
In the case series by Spiller et al. [11], patients with peak valproic acid concentrations above
450 μg/ml were more likely to develop significant clinical effects and have longer hospital stays
(P < 0.05). Also, acute toxicity seems to be less severe in patients who are regularly taking
valproate [36].
Few fatalities of valproic acid overdose are reported in the literature [11, 27, 35–41]. Deaths
were associated with plasma concentrations ranging from 305.4 μg/ml [37] to 1970 μg/ml [27].
In our study, the highest related VPA level was 660 μg/ml; however, the intoxication in this
case was non-lethal.
6. Conclusions
1. Positive correlation of the serum VPA concentrations with diastolic blood pressure,
poisoning severity score, Matthew’s coma scale and length of stay in hospital has been
found.
2. We failed to find any significant correlation between the VPA plasma level and the
remaining parameters.
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